|
Dr. Gewirtz is currently a Member-Institute for Human Gene Therapy, a Professor of Internal Medicine, and a Professor of Pathology and Laboratory Medicine at the University of Pennsylvania School of Medicine. He is also a Member of the Graduate Group in Cell and Molecular Biology and the Leader of the Stem Cell Biology and Therapeutics Program at the University of Pennsylvania Cancer Center.
A respected leader in antisense research, Dr. Gewirtz earned a BA at Colgate University in Marine Biology, received his MA from the State University of New York at Buffalo and an MD from the University at Buffalo, School of Medicine and Biomedical Sciences. He was a Resident in Medicine at Mt. Sinai Hospital, N.Y., a Fellow in Hematology/Oncology at Yale University and a Research Associate in Medicine at Yale University School of Medicine. | 